Christopher L. Carpenter, Chief Medical Officer at Rubius Therapeutics, Inc. (RUBY), sold 77,014 shares at $14.10 ($1.1M) on 2019-06-17, disclosed to the SEC on 2019-06-19.
Open-market sale of $1.1M RUBY by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.10 | 18,500 | $261K | 24.2% |
| 2 | $14.27 | 10,858 | $155K | 14.4% |
| 3 | $14.27 | 10,858 | $155K | 14.4% |
| 4 | $13.80 | 18,399 | $254K | 23.5% |
| 5 | $13.80 | 18,399 | $254K | 23.5% |
| Total | $14.00 avg | 77,014 |
| $1.1M |
| 100% |
| Filing → |
| RUBY | SELL | 2019-06-24 | $3K | — | Filing → |
| RUBY | SELL | 2019-03-19 | $760K | — | Filing → |